Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026)

Perspective Therapeutics has disclosed Receivables - Net across 16 years of filings, most recently posting $269000.0 for Q2 2026.

• In Q2 2026, Receivables - Net rose 19.56% year-over-year to $269000.0; the TTM figure through Jun 2026 stood at $269000.0 (up 19.56% YoY), while the FY2025 annual figure was $6000.0, down 94.83% from the prior year.
• Receivables - Net came in at $269000.0 for Q2 2026 at Perspective Therapeutics, up from $58000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $2.1 million in Q1 2022 to a low of $6000.0 in Q4 2025.
• Average Receivables - Net over 5 years is $777000.0, with a median of $634000.0 recorded in 2024.
• The largest YoY upside for Receivables - Net was 58.45% in 2025 against a maximum downside of 94.83% in 2025.
• Over 5 years, Receivables - Net stood at $1.4 million in 2022, then decreased by 14.53% to $1.2 million in 2023, then slumped by 90.04% to $116000.0 in 2024, then tumbled by 94.83% to $6000.0 in 2025, then soared by 4383.33% to $269000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $269000.0 in Q2 2026, $58000.0 in Q1 2026, and $6000.0 in Q4 2025.